Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications
- 1 September 1992
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3), 27-35
- https://doi.org/10.1016/0960-0760(92)90184-k
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growthJournal of Clinical Endocrinology & Metabolism, 1992
- Somatostatin receptors in malignant tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumorsBreast Cancer Research and Treatment, 1990
- Somatostatin receptors are present in small‐cell but not in non‐small‐cell primary lung carcinomas: Relationship to EGF‐receptorsInternational Journal of Cancer, 1990
- Somatostatin and Thyrotrophin‐Releasing Hormone Response and Receptor Status of a Thyrotrophin‐Secreting Pituitary Adenoma: Clinical and in vitro StudiesJournal of Neuroendocrinology, 1989
- Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulationsNeuroscience Letters, 1989
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- Evidence for two somatostatin-14 receptor types in rat brain cortexNeuroscience Letters, 1984
- SomatostatinNew England Journal of Medicine, 1983